awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37964916-5C8923B5-07D8-4A85-9830-CEA02EEC319B
Q37964916-5C8923B5-07D8-4A85-9830-CEA02EEC319B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37964916-5C8923B5-07D8-4A85-9830-CEA02EEC319B
Treatment of relapsed or refractory chronic lymphocytic leukemia.
P2860
Q37964916-5C8923B5-07D8-4A85-9830-CEA02EEC319B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37964916-5C8923B5-07D8-4A85-9830-CEA02EEC319B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
869df2e59665d4417d948188e70f49f33e29f8fc
P2860
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients.